Literature DB >> 20711617

Effective control of paroxysmal tachycardia with landiolol hydrochloride during cesarean section in a patient with hypertrophic obstructive cardiomyopathy.

Takakuni Abe1, Shunsuke Yamamoto, Norihisa Yasuda, Tetsuya Uchino, Seigo Hidaka, Satoshi Hagiwara, Koji Goto, Takayuki Noguchi.   

Abstract

Hypertrophic obstructive cardiomyopathy (HOCM) involves marked hypertrophy of cardiac muscle, resulting in myocardial ischemia and arrhythmia because of left ventricular diastolic dysfunction. In perioperative management of HOCM, hemodynamic stabilization is required, by prevention of arrhythmia and tachycardia and maintenance of preload and afterload. Here, we describe anesthesia management during cesarean section in a patient complicated by HOCM. The patient was a 27-year-old woman who underwent elective cesarean section scheduled at 36 weeks of pregnancy given her history of HOCM. She was managed with spinal anesthesia with monitoring of invasive blood pressure and arterial pressure cardiac output. Administration of landiolol hydrochloride was initiated, because of paroxysmal tachycardia after delivery. Approximately 5 min after initiation of administration, her heart rate decreased gradually and blood pressure rose. Circulatory dynamics stabilized and landiolol was discontinued 3 h after she was admitted to the intensive care unit. Her circulatory dynamics remained stable after discontinuation of landiolol, and she was moved to a general ward on the following day. She was discharged on postoperative day 14, with her child.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711617     DOI: 10.1007/s00540-010-1000-8

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  9 in total

1.  Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990.

Authors:  J L Hawkins; L M Koonin; S K Palmer; C P Gibbs
Journal:  Anesthesiology       Date:  1997-02       Impact factor: 7.892

2.  [Cardiovascular and respiratory responses to prostaglandin F2 alpha and methylergometrin during cesarian section (author's transl)].

Authors:  M Oda; K Watanabe; Y Fukushima; T Hirota; N Yamauchi; M Aono; Y Tominaga
Journal:  Masui       Date:  1979-11

3.  [Anesthesia for a cesarean section on a patient with hypertrophic obstructive cardiomyopathy (HOCM)].

Authors:  M Kobori; T Suzuki; Y Masuda; M Namiki; S Hatanaka; M Ban; A Hosoyamada
Journal:  Masui       Date:  1985-11

Review 4.  [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].

Authors:  Yasushi Mio
Journal:  Masui       Date:  2006-07

5.  [Effects of methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section].

Authors:  Takehiko Kikutani; Mariko Kikutani; Masayuki Oshima; Kikuzou Sugimoto; Yoichi Shimada
Journal:  Masui       Date:  2006-05

6.  [Case in which landiolol hydrochloride improved left ventricular outflow tract obstruction with systolic anterior motion of the mitral valve following mitral valve plasty].

Authors:  Tetsuya Kushikata; Hiroshi Hashimoto; Eiji Hashiba; Kozo Fukui; Kazuo Itoh; Kazuyoshi Hirota
Journal:  Masui       Date:  2006-01

7.  [Successful weaning from cardiopulmonary bypass with administration of landiolol hydrochloride in a patient with hypertrophic obstructive cardiomyopathy].

Authors:  Masahide Shinzawa; Toshihiro Nohmi; Masanobu Tsuzuki; Yoshihiko Ohnishi; Masakazu Kuro
Journal:  Masui       Date:  2005-07

Review 8.  [Anesthetic management of patients with hypertrophic obstructive cardiomyopathy undergoing non-cardiac surgery].

Authors:  Kyung-Ho Chang; Erika Sano; Yuichiro Saitoh; Kazuo Hanaoka
Journal:  Masui       Date:  2004-08

9.  A short-acting beta-blocker, landiolol, attenuates systolic anterior motion of the mitral valve after mitral valve annuloplasty.

Authors:  Takeshi Omae; Isao Tsuneyoshi; Akiko Higashi; Akira Matsunaga; Ryuzo Sakata; Yuichi Kanmura
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.